Search results
Hypothyroidism in teens: What to expect with an underactive thyroid
Medical News Today· 4 days agoHypothyroidism is when the thyroid gland produces too little thyroid-stimulating hormone (TSH). or...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 19 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class costimulatory bispecific antibody< ...
InDevR Introduces Latest Solution for Influenza Vaccine Manufacturers, OmniFlu HA, to Simplify...
Morningstar· 2 days agoValidated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and quantification addresses the unique challenges faced by vaccine developers and manufacturers.BOULDER, CO ...
4 Ways Vaccine Skeptics Mislead You on Measles and More
The Weatherford Democrat· 20 hours agoMeasles is on the rise in the United States. In the first quarter of this year, the number of cases...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO), today announced the availability of SIMLANDI (adalimumab-ryvk ...
ONLY ON 4: Pitt research team develops sensor to detect fentanyl
WTAE Pittsburgh· 4 days agoA University of Pittsburgh research team led by chemistry professor Alexander Star has developed a...
Earnings call: Inhibikase Therapeutics reports on drug trials progress
Investing.com· 6 days agoInhibikase Therapeutics, a biopharmaceutical company focused on developing treatments for...
TB has reclaimed its place as the world’s biggest infectious killer – but are its days numbered?
The Telegraph via Yahoo News· 4 days agoIn the few minutes it takes to read this article, some 15 people are likely to have died from...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO),today announced the availability of SIMLANDI (adalimumab-ryvk) ...
Structural insights into the cross-exon to cross-intron spliceosome switch - Nature
Nature· 2 days agoCryo-electron microscopy structures of cross-exon pre-B and B-like complexes contribute new insights into the molecular mechanisms that mediate the switch from a cross-exon to a cross-intron organized spliceosome.